DEEPAI share price, P/E, ROE & financials

Deep Health AI India (BSE: DEEPAI) is loss-making over the last 12 months, losing ₹3.40 Cr, so a P/E ratio does not apply. Its share price on 6 Nov 2026 was ₹1.64, 84% below its 52-week high. Sales fell 18% a year over 3 years. It has almost no debt, and its dividend yield is 12%. It is a small-cap company with a market cap of ₹24 Cr, ranked 6th of 6 Health Information Services companies by market cap; the shares fell 82% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Jun 2026.How we calculate this

past year

Open: ₹1.68
Day high: ₹1.68
Day low: ₹1.62
Prev. close: ₹1.64
Volume: 1.3 L

Health check

1 fair · 5 to check

ReturnsBehind
−81.9% over a year, better than 0 of 5 peers.
Price tagLoss-making
Earnings were negative over the last 12 months.
GrowthShrinking
Sales −17.9%, profit −3.4% a year over 3 years.
ProfitabilityWeak
ROCE 3.2% vs peer median 15.3%.
Balance sheetFair
Practically debt-free, Piotroski 5 of 9.
Red flags4 to check
Loss-making over the last twelve months.

Compared with 5 industry peers. Computed from reported figures. Educational, not a recommendation.

Health Information Services

5 listed peers. Screen the industry

Small cap

₹24 Cr, #6 of 6 in its industry by size.

Market sensitivity

Measuring against the NIFTY 50…

Key metrics

Last 12 months to Jun 2026: sales ₹2 Cr · profit ₹−3 Cr

Market cap: ₹24 Cr; Small cap
P/E: 14.9; Industry 26.0
Price to book: 0.65; Peers 4.37
Dividend yield: 12.20%
ROE: −8.6%; Peers 13.2%
ROCE: 3.2%; Peers 15.3%
Debt to equity: 0.01; Debt ₹0.39 Cr
EPS (TTM): ₹0.11
OPM (TTM): 60.7%; Net margin −179.2%
Sales growth: +200.0%; Latest quarter vs a year ago
Profit growth: −3472.4%; Latest quarter vs a year ago
Price to sales: 12.47; EV/EBITDA −21.1

Strengths

Practically debt-free.
Dividend yield of 12.20%.
Quarterly sales up 200.0% on a year ago.

Risks to check

Loss-making over the last twelve months.
Return on equity is low at −8.6%.
Quarterly profit down 3472.4% on a year ago.
84% below its 52-week high.

Derived automatically from reported figures. Not a recommendation.

About Deep Health AI India

Deep Health AI India Limited engages in the manufacturing and sales of gold and diamond studded jewelry products in India. The company operates through two segments, Diamond Jewellery and Pharmaceuticals. It provides pendants, nose pins, rings, bangles, earrings, pendant sets, necklace sets, bracelets, and other jewelry products. The company also deals in loose diamonds, solitaires, and gold frames, as well as offers rough and polished diamonds. In…

Headquarters: Udaipur
Employees: 8
Sector: Healthcare
ISIN: INE005G01026
Website: deephealthaiindia.com

Price range

52 weeks

₹1.48₹10.29

Today

₹1.62₹1.68

Avg volume (3M): 3.3 L
1-year return: minus 81.9%
From 52-week high: minus 84.1%

Peers · Health Information Services

Compare with peers Screen the whole industry

Company
IKSInventurus Knowledge Solutions	1,657.10	minus 5.70%	27,799	35.4	8.32	29.6%	28.2%	33.7%	45.7%	33.2%	0.00%	plus 5.4%
SAGILITYSagility	43.46	minus 0.78%	20,345	19.8	1.98	12.5%	10.7%	24.4%	19.5%	86.0%	0.69%	minus 15.1%
INDGNIndegene	609.75	minus 0.59%	14,684	35.9	4.37	15.3%	13.2%	16.5%	15.0%	14.7%	0.37%	plus 13.8%
FABTECHFabtech Technologies	131.98	minus 1.78%	587	15.5	1.21	11.8%	12.9%	2.4%	28.3%	20.8%	0.45%	minus 43.5%
TAKETAKE	12.57	plus 4.84%	186	32.2	6.10	15.4%	42.1%	−0.9%	−34.1%	–	0.00%	minus 49.8%
DEEPAIDeep Health AI India	1.64	0.00%	24	14.9	0.65	3.2%	3.1%	−457.4%	−17.9%	−3.4%	12.20%	minus 81.9%
Median of 5 peers	–	−0.78%	14,684	32.2	4.37	15.3%	13.2%	16.5%	19.5%	27.0%	0.37%	−15.1%

Quarterly results

Consolidated, ₹ crore

SalesSelect a row below to chart it

Mar 25	Jun 25	Dec 25	Mar 26	Jun 26
0.5	0.2	0.5	0.3	0.5
–	–	–	minus 44.4%	+200.0%
0.2	0.2	0.4	0.2	2.5
0.2	−0.1	0.1	0.1	−2.1
52.4%	−34.7%	20.8%	21.3%	−457.1%
0.2	0.2	3.6	0.4	−0.1
0	0	0	0	0
0	0	0	0	0
–	–	–	−5.8	–
0.4	0.1	3.7	−5.3	−2.1
10.3%	33.0%	16.8%	19.3%	–
0.4	0.1	3	−4.5	−2.1
–	–	–	minus 1385.1%	minus 3472.4%
0.07	0.01	0.21	-0.48	-0.15

Sep 25 not reported by the data source.

Profit & loss

Yearly, ₹ crore

Sales CAGR 3Y: −17.9%
Profit CAGR 3Y: −3.4%
EPS CAGR 3Y: −67.1%
ROE: −8.6%

Net profitSelect a row below to chart it

Mar 2023	Mar 2024	Mar 2025	Mar 2026
7.7	2.6	1.3	4.3
–	minus 66.7%	minus 50.7%	+237.5%
6.1	1.7	0.8	2.6
1.6	0.8	0.5	1.6
21.0%	31.9%	36.2%	38.4%
0.2	1	0.7	2.2
0.1	0.2	0.1	0
0	0	0	0
−0	−1	0	−2.2
1.7	0.6	1.1	1.6
27.5%	28.4%	21.3%	29.0%
1.3	0.4	0.9	1.1
–	minus 66.8%	+110.3%	+29.4%
3.10	0.13	0.17	0.11

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore

Total assetsSelect a row below to chart it

Mar 2023	Mar 2024	Mar 2025	Mar 2026
4.8	4.8	4.8	14.4
9.9	15.6	17.5	37
3.9	1.7	0.6	0.4
1.3	1	1	0.3
19.9	23.1	23.9	52.1
4.5	0	0	0
0	8	–	27.4
6	0.1	0.1	8.3
9.4	14.9	23.9	16.3
19.9	23.1	23.9	52.1

Cash flow

Yearly, ₹ crore

Cash from operationsSelect a row below to chart it

Mar 2023	Mar 2024	Mar 2025	Mar 2026
0	−5.4	1.3	−3.7
−0	−2.2	−0.2	−29.2
0.1	5	−1.2	37.9
0	−2.7	−0	5
−0	–	−0	−0
−0	−5.4	1.3	−3.7
–	–	−1.1	−1.4

Shareholding pattern

This company is listed only on BSE, so there’s no NSE category split. See Major shareholders below for the named holders.

Major shareholders

BSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you